The adenoviral E1A induces p21WAF1/CIP1 expression in cancer cells

S Mahmoud A Najafi1, Zheng Li, Keishi Makino

  • 1Department of Molecular and Cellular Oncology, Box 108, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA.

Insights

Adenovirus-5 E1A proteins suppress tumor growth by increasing cyclin-dependent kinase inhibitor p21(WAF1/CIP1) expression. The 13S E1A protein specifically activates the p21 promoter in cancer cells, offering new therapeutic insights.

Area of Science:

  • Molecular biology
  • Cancer research
  • Virology

Background:

  • Adenovirus-5 E1A proteins are transcriptional regulators with anti-tumor properties.
  • The precise mechanism of E1A-mediated tumor suppression is not fully elucidated.
  • E1A gene therapy has shown promise in clinical trials.

Purpose of the Study:

  • To investigate the molecular mechanism underlying E1A's anti-tumor activity.
  • To determine the role of E1A in regulating cell growth inhibitors.
  • To explore the differential activity of E1A isoforms on tumor cells.

Main Methods:

  • Analysis of E1A protein expression from 13S and 12S mRNA.
  • Assessing the impact of E1A on cyclin-dependent kinase (CDK) inhibitor p21(WAF1/CIP1) levels.
  • Investigating E1A-mediated transactivation of the p21 promoter via Sp1 sites in cancer and normal cells.

Main Results:

  • E1A significantly increases the expression of p21(WAF1/CIP1), a cell growth inhibitor.
  • The 13S E1A isoform, but not the 12S isoform, transactivates the p21 promoter.
  • This E1A-induced transactivation is specific to cancer cells and does not occur in normal cells.

Conclusions:

  • E1A's tumor suppressive function is partly mediated by upregulating p21(WAF1/CIP1).
  • The 13S E1A isoform plays a key role in this process through Sp1-dependent promoter activation in cancer cells.
  • These findings provide novel insights into E1A's mechanism of action and potential clinical applications in cancer therapy.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...